Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Papers of the Week
Annotation


Palop JJ, Jones B, Kekonius L, Chin J, Yu GQ, Raber J, Masliah E, Mucke L. Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits. Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9572-7. PubMed Abstract

  
Comments on Paper and Primary News
  Primary News: Calbindin Study: Is Calcium the Molecular Handle on Dysfunction in AD?

Comment by:  Vincent Marchesi, ARF Advisor
Submitted 21 July 2003  |  Permalink Posted 21 July 2003

Amyloid peptide-induced behavioral deficits in transgenic models of Alzheimer's disease are tightly linked to depletion of calcium-dependent proteins in granule cells of the dentate gyrus.

This work builds on earlier observations that described the reduction in levels of calbindin D28K, a high-affinity calcium-binding protein, in the brains of patients with various neurodegenerative diseases. Transgenic mice carrying mutant forms of human APP accumulate amyloid plaques and exhibit learning deficits. Careful immunochemical studies show that there are also significant reductions in the levels of calbindin D28K (CB) and c-Fos in the brains of these mice, and that these seem to correlate more with the levels of soluble Ab peptide levels in brain extracts than with the amount of accumulated amyloid plaque. Reduced levels of CB were also found in brain samples from patients with AD.

The strength of this study is the careful correlation of learning defects in genetically manipulated mice that show age-dependent changes in the amounts of a well-defined...  Read more


  Primary News: Calbindin Study: Is Calcium the Molecular Handle on Dysfunction in AD?

Comment by:  Roland Pochet
Submitted 26 July 2003  |  Permalink Posted 3 August 2003
  I recommend this paper

I would like to stress that already in 1993, Sutherland MK, Wong L, Somerville MJ, Yoong LK, Bergeron C, Parmentier M, McLachlan DR published in Brain Res Mol Brain Res. 1993 Apr;18(1-2):32-42 Reduction of calbindin-28k mRNA levels in Alzheimer as compared to Huntington hippocampus. Indeed the correlation between learning deficit and calbinbin is indeed appealing and deserve further experiments. What about cross breeding knock out mice for calbindin and APP transgenic mice?

View all comments by Roland Pochet

  Primary News: Calbindin Study: Is Calcium the Molecular Handle on Dysfunction in AD?

Comment by:  Wallace Dembski
Submitted 23 July 2003  |  Permalink Posted 3 August 2003
  I recommend this paper
  Submit a Comment on this Paper
Cast your vote and/or make a comment on this paper. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend this paper

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
 
 

REAGENTS/MATERIAL:

Studied mouse line J20 having (hAPP SweInd) FAD mutations and line I5 wildtype hAPP (hAPPWT) and C57BL/6J non-TG breeders.

Immunofluorescent double staining or general avidin-biotin/peroxidase staining was performed on human brains obtained from Alzheimer's Disease Research Center with the following antibodies: rabbit anti-calbindin (1:15,000, Swant, Bellinzona, Switzerland); rabbit anti-c-Fos (1:10,000, Ab-5, Oncogene); mouse monoclonal anti-Neu-N (1:5,000, Chemicon); or mouse monoclonal anti-Abeta 3D6 (1:500, Elan Pharmaceuticals, South San Francisco, CA), and then with fluorescein-labeled donkey anti-rabbit (1:300, Jackson ImmunoResearch); Texas red-labeled donkey anti-mouse (1:300, Jackson ImmunoResearch); biotinylated goat anti-rabbit (1:200, Vector Laboratories); or biotinylated goat anti-mouse (1:600, Vector Laboratories). Diaminobenzidine was used as a chromagen. Immunofluorescence was visualized by confocal microscopy.

Western Blots were probed with rabbit anti-CB (1:20,000, Swant); mouse monoclonal anti-hApp 8E5 (1:1,000, Elan Pharmaceuticals); or mouse monoclonal anti-alpha-tubulin B512 (1:100,000, Sigma).

Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad